Jac Olivol Herbal Products Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 04-07-2024
- Paid Up Capital ₹ 2.00 M
as on 04-07-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Profit -5068.40%
(FY 2019)
- Ebitda -4726.78%
(FY 2019)
- Net Worth -155.09%
(FY 2019)
- Total Assets 125.81%
(FY 2019)
About Jac Olivol Herbal Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajarshi Das, Tapati Das, Ritesh Das, and One other member serve as directors at the Company.
- CIN/LLPIN
U36999WB2018PTC224404
- Company No.
224404
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jac Olivol Herbal Products?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajarshi Das  | Director | 18-Jan-2018 | Current |
| Tapati Das | Additional Director | 22-Mar-2024 | Current |
| Ritesh Das | Director | 18-Jan-2018 | Current |
| Rashmoy Das | Director | 18-Jan-2018 | Current |
Financial Performance of Jac Olivol Herbal Products.
Jac Olivol Herbal Products Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 5068.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 155.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jac Olivol Herbal Products?
In 2020, Jac Olivol Herbal Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Tapati Domestic Products LlpActive 7 years 9 months
Rajarshi Das, Tapati Das and 2 more are mutual person
- Hahnemann Laboratory Drugs & Cosmetics Private LimitedActive 2 years 3 months
Rajarshi Das, Tapati Das and 1 more are mutual person
- Hahnemann's Jac Olivol Group Of Products Private LimitedActive 3 years 7 months
Rajarshi Das, Tapati Das and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jac Olivol Herbal Products?
Unlock and access historical data on people associated with Jac Olivol Herbal Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jac Olivol Herbal Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jac Olivol Herbal Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
